FBLG (FibroBiologics) Change In Other Working Capital : $-0.25 Mil (TTM As of Sep. 2024)

View and export this data going back to 2024. Start your Free Trial

What is FibroBiologics Change In Other Working Capital?

FibroBiologics's Change In Other Working Capital for the quarter that ended in Sep. 2024 was $-0.10 Mil. It means FibroBiologics's Other Working Capital declined by $0.10 Mil from Jun. 2024 to Sep. 2024 .

FibroBiologics's Change In Other Working Capital for the fiscal year that ended in Dec. 2023 was $-0.31 Mil. It means FibroBiologics's Other Working Capital declined by $0.31 Mil from Dec. 2022 to Dec. 2023 .

FibroBiologics Change In Other Working Capital Historical Data

The historical data trend for FibroBiologics's Change In Other Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

FibroBiologics Change In Other Working Capital Chart

FibroBiologics Annual Data

Trend

Dec21

Dec22

Dec23

Change In Other Working Capital

-0.02

-0.23

-0.31

FibroBiologics Quarterly Data
	Dec21	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Change In Other Working Capital	Get a 7-Day Free Trial						0.10	0.05	-0.10	-0.10	-0.10

FibroBiologics Change In Other Working Capital Calculation

Change In Other Working Capital is any increase or decrease between periods of other working capital that are not otherwise classified.

Change In Other Working Capital for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.25 Mil.

FibroBiologics Change In Other Working Capital Related Terms

Thank you for viewing the detailed overview of FibroBiologics's Change In Other Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

FibroBiologics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » FibroBiologics Inc (NAS:FBLG) » Definitions » Change In Other Working Capital

Comparable Companies

Traded in Other Exchanges

N/A

Address

455 E. Medical Center Boulevard, Suite 300, Houston, TX, USA, 77598

Website

https://www.fibrobiologics.com

FibroBiologics Inc is a clinical-stage cell therapy company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with significant unmet medical needs, including degenerative disc disease, multiple sclerosis, wound healing, and certain cancers, and potential extension of life applications including thymic and splenic involution reversal.